“3 Key Trends” with Mahesh Bhalgat
Biologics will be a major contributor to our growth, says Syngene CEO Jonathan Hunt
The landscape of STEM has significantly transformed
Innovative tumour models spearhead cancer research advancements
Fostering inclusion Empowering women in STEM
Power of AI to identify better drug targets and drug candidates
Panbela announces issuance of new patent in Australia. Patent is for claims of a novel process for the production of SBP-101
Syngene expects outsourcing boost from West
CDMOs will play a vital role in bringing CGT and mRNA technologies to market
Indian CDMOs now scout for capital-intensive projects and invest in new technologies for global orders
